PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) FOR NEWLY DIAGNOSED GLIOBLASTOMA

被引：0

作者：

Ahluwalia, Manmeet ^{[1
]}

Reardon, David ^{[2
]}

Abad, Ajay ^{[3
]}

Curry, William ^{[4
]}

Wong, Eric ^{[5
]}

Peereboom, David ^{[1
]}

Belal, Ahmed ^{[3
]}

Qiu, Jingxin ^{[3
]}

Mogensen, Kathleen ^{[3
]}

Schilero, Cathy ^{[1
]}

Casucci, Danielle ^{[3
]}

Mechtler, Laszlo ^{[3
]}

Uhlmann, Erik ^{[3
]}

Ciesielski, Michael ^{[3
]}

Fenstermaker, Robert ^{[3
]}

机构：

[1] Cleveland Clin, Cleveland, OH 44106 USA

[2] Dana Farber Canc Inst, Boston, MA 02115 USA

[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[4] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02115 USA

[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

来源：

NEURO-ONCOLOGY | 2018年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ATIM-41

引用

页码：10 / 11

页数：2

共 50 条

[41] MRI CHANGES IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED AS PART OF A PHASE II TRIAL WITH BAVITUXIMAB, RADIATION, AND TEMOZOLOMIDE [J].

Ly, Ina ;

Cardona, Jonathan ;

Beers, Andrew ;

Chang, Ken ;

Brown, James ;

Reardon, David ;

Arrillaga-Romany, Isabel ;

Dietrich, Jorg ;

Forst, Deborah ;

Lee, Eudocia ;

Jordan, Justin ;

Nayak, Lakshmi ;

Wen, Patrick ;

Batchelor, Tracy ;

Kalpathy-Cramer, Jayashree ;

Gerstner, Elizabeth .

NEURO-ONCOLOGY, 2018, 20 :191-191

[42] A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study [J].

Schuster, James ;

Lai, Rose K. ;

Recht, Lawrence D. ;

Reardon, David A. ;

Paleologos, Nina A. ;

Groves, Morris D. ;

Mrugala, Maciej M. ;

Jensen, Randy ;

Baehring, Joachim M. ;

Sloan, Andrew ;

Archer, Gary E. ;

Bigner, Darell D. ;

Cruickshank, Scott ;

Green, Jennifer A. ;

Keler, Tibor ;

Davis, Thomas A. ;

Heimberger, Amy B. ;

Sampson, John H. .

NEURO-ONCOLOGY, 2015, 17 (06) :854-861

[43] Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma [J].

Faye, Mame Daro ;

Easaw, Jacob ;

De Robles, Paula ;

Agnihotram, Raman ;

Torres-Vasquez, Alexander ;

Lamonde, Frederic ;

Petrecca, Kevin ;

Owen, Scott ;

Panet-Raymond, Valerie ;

Shenouda, George ;

Souhami, Luis ;

Azam, Maryam ;

Hossain, Bushra ;

Alkass, Jad ;

Sabri, Siham ;

Abdulkarim, Bassam .

NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)

[44] PRICOTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA [J].

Glas, M. ;

Scheffler, B. ;

Lazaridis, L. ;

Herrlinger, U. ;

Pierscianek, D. ;

Sure, U. ;

Proescholdt, M. ;

Hau, P. ;

Hense, J. ;

Kleinschnitz, C. ;

Grosu, A. ;

Stuschke, M. ;

Kebir, S. .

NEURO-ONCOLOGY, 2018, 20 :243-243

[45] Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial [J].

Vaz, M. A. ;

del Barco, S. ;

Sepulveda, J. M. ;

Alonso, M. ;

Pineda, E. ;

Balana, C. ;

Martinez-Garcia, M. ;

Girones, R. .

ANNALS OF ONCOLOGY, 2023, 34 :S393-S393

[46] A PHASE 0 'TRIGGER' TRIAL OF NIRAPARIB IN NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS [J].

Sanai, Nader ;

Margaryan, Tigran ;

Molloy, Jennifer ;

Knight, William ;

Harmon, Jocelyn ;

Hong, Amy ;

Wanebo, John ;

Kennedy, William ;

Garcia, Michael ;

Barani, Igor ;

Yoo, Wonsuk ;

Tien, An-Chi ;

Tovmasyan, Artak ;

Mehta, Shwetal .

NEURO-ONCOLOGY, 2022, 24 :73-73

[47] A phase 0 'trigger' trial of pamiparib in newly diagnosed and recurrent glioblastoma patients [J].

Sanai, N. ;

Mehta, S. N. ;

Chang, Y-W. ;

Jiang, J. ;

Molloy, J. ;

Pennington-Krygier, C. ;

Harmon, J. ;

Hong, A. ;

Wanebo, J. ;

Kennedy, W. ;

Garcia, M. ;

Barani, I. ;

Yoo, W. ;

Tovmasyan, A. ;

Tien, A-C. ;

Li, J. .

ANNALS OF ONCOLOGY, 2022, 33 (07) :S670-S670

[48] A phase 0/2 trigger trial of niraparib in patients with newly diagnosed glioblastoma [J].

Mehta, Shwetal ;

Sanai, Nader ;

Margaryan, Tigran ;

Molloy, Jennifer ;

Zhang, Hualin ;

Knight, William ;

Harmon, Jocelyn ;

Hong, Amy ;

Wanebo, John ;

Braun, Kelly ;

Kennedy, William R. ;

Garcia, Michael A. ;

Barani, Igor J. ;

Yoo, Wonsuk ;

Tien, An-Chi ;

Tovmasyan, Artak .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

[49] Phase 2 trial of bavituximab with chemoradiation and adjuvant temozolomide in newly diagnosed glioblastoma [J].

Ly, Ina ;

Richardson, Leland ;

Liu, Mofei ;

Muzikansky, Alona ;

Lou, Kevin ;

Reardon, David A. ;

Arrillaga-Romany, Isabel ;

Forst, Deborah Anne ;

Jordan, Justin T. ;

Lee, Eudocia Quant ;

Dietrich, Jorg ;

Nayak, Lakshmi ;

Wen, Patrick Y. ;

Chukwueke, Ugonma Nnenna ;

Giobbie-Hurder, Anita ;

Choi, Bryan D. ;

Batchelor, Tracy ;

Kalpathy-Cramer, Jayashree ;

Curry, William T. ;

Gerstner, Elizabeth R. .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

[50] A PHASE 0 'TRIGGER' TRIAL OF PAMIPARIB IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA PATIENTS [J].

Sanai, Nader ;

Chang, Yu-Wei ;

Jiang, Jun ;

Molloy, Jennifer ;

Montgomery, Chelsea ;

Harmon, Jocelyn ;

Hong, Amy ;

Wanebo, John ;

Kennedy, William ;

Garcia, Michael ;

Barani, Igor ;

Yoo, Wonsuk ;

Tovmasyan, Artak ;

Tien, An-Chi ;

Li, Jing ;

Mehta, Shwetal .

NEURO-ONCOLOGY, 2022, 24 :82-82

← 1 2 3 4 5 →